BIONTECH, ONCOC4 ANNOUNCE PROMISING RESULTS FOR POTENTIAL LUNG CANCER ANTIBODY TRIAL
Sat 03 June 2023: German biotech firm BioNTech and US biopharmaceutical company OncoC4 announced on Friday that they had gotten promising results in a mid-stage lung cancer trial. “The jointly developed immunotherapy candidate was found to shrink tumors in close to 30% of participants,” the two companies said in a joint statement. They noted that […]
Continue Reading
